| 1 |
cytomegalovirus
(15518 times)
|
Transplantation
(1955 times)
|
EBV (1108 times)
PCR (840 times)
HSV (583 times)
|
1969 Interaction between cytomegalovirus and Newcastle disease virus as mediated by intrinsic interference.
|
| 2 |
Cucumber mosaic virus
(884 times)
|
Virology
(298 times)
|
CP (91 times)
TMV (79 times)
PVY (48 times)
|
1975 Cucumber mosaic virus RNA contains 7-methyl guanosine at the 5'-terminus of all four RNA species.
|
| 3 |
conventional mechanical ventilation
(407 times)
|
Critical Care
(98 times)
|
HFOV (78 times)
PEEP (39 times)
HFO (37 times)
|
1975 Treatment of flail chest. Use of intermittent mandatory ventilation and positive end-expiratory pressure.
|
| 4 |
cytomegalovirus infection
(57 times)
|
Medicine
(13 times)
|
CI (3 times)
AIDS (2 times)
HIV (2 times)
|
1981 [Cytomegalovirus pneumonia in primarily healthy adults].
|
| 5 |
cytomegalovirus immediate-early promoter
(38 times)
|
Molecular Biology
(11 times)
|
TK (5 times)
rAAV (4 times)
EF-1alpha (3 times)
|
1992 Improved gene expression by a U3-based retroviral vector.
|
| 6 |
cucumber mosaic cucumovirus
(37 times)
|
Virology
(16 times)
|
CP (5 times)
BMV (3 times)
ELISA (3 times)
|
1992 Differentiation of cucumber mosaic virus isolates using the polymerase chain reaction.
|
| 7 |
cisplatin, methotrexate and vinblastine
(27 times)
|
Neoplasms
(12 times)
|
M-VAC (7 times)
CR (2 times)
TCC (2 times)
|
1985 Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.
|
| 8 |
commercial motor vehicle
(27 times)
|
Traumatology
(8 times)
|
OSA (5 times)
FMCSA (3 times)
AHI (2 times)
|
2001 Physical qualification of drivers; medical examination; certificate. Federal Motor Carrier Safety Administration (FMCSA), DOT. Final rule.
|
| 9 |
canalicular membrane vesicles
(21 times)
|
Biochemistry
(10 times)
|
cMOAT (4 times)
DNP-SG (4 times)
EHBR (4 times)
|
1989 The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles.
|
| 10 |
cribriform-morular variant
(17 times)
|
Pathology
(8 times)
|
PTC (13 times)
FAP (11 times)
APC (2 times)
|
2001 Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma.
|
| 11 |
cytomegalovirus promoter
(17 times)
|
Allergy and Immunology
(3 times)
|
EGFP (2 times)
A-I (1 time)
ABI (1 time)
|
2000 The effect of promoter strength in adenoviral vectors in hyperplastic synovium.
|
| 12 |
closed mitral valvotomy
(14 times)
|
Cardiology
(8 times)
|
BMV (4 times)
MVR (3 times)
RV (2 times)
|
1985 Fate of tricuspid regurgitation after closed valvotomy for mitral stenosis.
|
| 13 |
central macular volume
(13 times)
|
Ophthalmology
(7 times)
|
BCVA (11 times)
CMT (11 times)
DME (6 times)
|
2015 Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degeneration.
|
| 14 |
controlled mandatory ventilation
(12 times)
|
Anesthesiology
(4 times)
|
PEEP (3 times)
AC (1 time)
ALV (1 time)
|
1992 [A study of changes in extravascular lung water after extracorporeal circulation--clinical and experimental studies of decremental factors].
|
| 15 |
clinical manifestations of cytomegalovirus
(11 times)
|
Transplantation
(2 times)
|
PCR (3 times)
AIDS (1 time)
BAL (1 time)
|
1988 Treatment of cytomegalovirus retinitis in patients with AIDS.
|
| 16 |
cell-mediated immunity to cytomegalovirus
(8 times)
|
Allergy and Immunology
(4 times)
|
HSV (2 times)
AIDS (1 time)
CMI (1 time)
|
1978 Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans.
|
| 17 |
contrast media volume
(8 times)
|
Cardiology
(4 times)
|
PCI (5 times)
CI-AKI (3 times)
CIN (2 times)
|
2009 Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention.
|
| 18 |
cytomegalovirus disease
(7 times)
|
Medicine
(5 times)
|
CG (1 time)
CI (1 time)
eGFR (1 time)
|
1974 Forty-day fever. An epidemic of cytomegalovirus disease in a renal transplant population.
|
| 19 |
cytomegalovirus retinitis
(7 times)
|
Ophthalmology
(5 times)
|
AIDS (1 time)
EA (1 time)
HIV (1 time)
|
1994 [Diagnostic aspects and frequency of retrocorneal precipitates in diagnosis of cytomegalovirus retinitis in the HIV+ patient].
|
| 20 |
common method variance
(6 times)
|
Psychology
(4 times)
|
MI (1 time)
MMPI (1 time)
ROA (1 time)
|
2001 Accounting for common method variance in cross-sectional research designs.
|
| 21 |
contingent magnetic variation
(5 times)
|
Brain
(2 times)
|
MEG (2 times)
SMA (2 times)
ANT (1 time)
|
1994 The magnetic counterpart of the contingent negative variation.
|
| 22 |
beta-herpesvirus-cytomegalovirus
(4 times)
|
Gastroenterology
(1 time)
|
HHV (3 times)
CI (1 time)
CIN1 (1 time)
|
1986 Effect of herpesvirus infections on T-lymphocyte subpopulations and blastogenic responses in renal transplant recipients receiving cyclosporine.
|
| 23 |
capillary microextraction of volatiles
(4 times)
|
Chemistry Techniques, Analytical
(2 times)
|
DPA (2 times)
NG (2 times)
2,4-DNT (1 time)
|
2013 High-efficiency headspace sampling of volatile organic compounds in explosives using capillary microextraction of volatiles (CMV) coupled to gas chromatography-mass spectrometry (GC-MS).
|
| 24 |
cetacean morbillivirus
(4 times)
|
Veterinary Medicine
(3 times)
|
CDV (3 times)
PDV (3 times)
RT-PCR (2 times)
|
1999 Morbillivirus infections, with special emphasis on morbilliviruses of carnivores.
|
| 25 |
cranial medial ventricular
(4 times)
|
Neurology
(2 times)
|
AV (1 time)
GPs (1 time)
RA (1 time)
|
1998 Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility.
|
| 26 |
Cytomegalovirus antigen
(4 times)
|
Biology
(1 time)
|
ATL (1 time)
CI (1 time)
CMI (1 time)
|
1992 Cytomegalovirus infection in children with blood diseases.
|
| 27 |
cardiac metabolic volume
(3 times)
|
Cardiology
(2 times)
|
CS (2 times)
DA (2 times)
BW (1 time)
|
2017 Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.
|
| 28 |
caudal mesenteric vein
(3 times)
|
General Surgery
(3 times)
|
CMA (2 times)
|
1995 Local colonic blood pressure degree through aortic reconstruction procedures: a porcine model.
|
| 29 |
Chinese milk vetch
(3 times)
|
Natural Science Disciplines
(2 times)
|
FN (1 time)
GC (1 time)
GHGI (1 time)
|
2016 Chinese Milk Vetch as Green Manure Mitigates Nitrous Oxide Emission from Monocropped Rice System in South China.
|
| 30 |
cytomegalic inclusion virus
(3 times)
|
Radiotherapy
(1 time)
|
EIA (1 time)
IHA (1 time)
PLA (1 time)
|
1975 Cytomegalic virus infection of bowel in adults.
|
| 31 |
thaliana-Cucumber mosaic virus
(3 times)
|
Microbiological Phenomena
(1 time)
|
alpha-MMC (1 time)
JA (1 time)
ROS (1 time)
|
2007 The relationship of within-host multiplication and virulence in a plant-virus system.
|
| 32 |
adenovirus-cytomegalovirus
(2 times)
|
Otolaryngology
(1 time)
|
ADSCs (1 time)
ATRA (1 time)
BMP-14 (1 time)
|
2001 All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
|
| 33 |
canarypox vector-expressing cytomegalovirus
(2 times)
|
Communicable Diseases
(2 times)
|
CTL (1 time)
pp65 (1 time)
|
1999 A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
|
| 34 |
cerebral microvessels
(2 times)
|
Neurology
(1 time)
|
ACh (1 time)
AD (1 time)
NIC (1 time)
|
1994 Nicotinic cholinergic receptors associated with mammalian cerebral vessels.
|
| 35 |
cicer milkvetch
(2 times)
|
Veterinary Medicine
(1 time)
|
ALF (2 times)
BFT (2 times)
DM (1 time)
|
2019 Effect of tannin-containing hays on enteric methane emissions and nitrogen partitioning in beef cattle1.
|
| 36 |
CMV R-Gene, France
(2 times)
|
Microbiology
(2 times)
|
ESRD (2 times)
PRTRs (2 times)
|
2019 Detection of cytomegalovirus disease by real-time quantitative PCR targeting immediate early gene (ppUL83) in different samples among post-renal-transplant recipients.
|
| 37 |
color-map virtual touch tissue imaging
(2 times)
|
Hematology
(1 time)
|
AUC (1 time)
OR (1 time)
ROC (1 time)
|
2021 The value of color-map virtual touch tissue imaging (CMV) in the differential diagnosis of benign and malignant breast lesions.
|
| 38 |
common methods for detecting cytomegalovirus
(2 times)
|
Communicable Diseases
(1 time)
|
CPE (1 time)
SV (1 time)
TC (1 time)
|
1988 Detection of cytomegalovirus in clinical specimens using shell vial centrifugation and conventional cell culture.
|
| 39 |
common-mode voltage
(2 times)
|
Biomedical Engineering
(2 times)
|
CMFB (1 time)
CMRR (1 time)
EIT (1 time)
|
1992 Common-mode feedback in electrical impedance tomography.
|
| 40 |
control mode ventilation
(2 times)
|
Critical Care
(1 time)
|
ACB (1 time)
BVV (1 time)
COPD (1 time)
|
1995 Oxygen cost of breathing for assisted spontaneous breathing modes: investigation into three states of pulmonary function.
|
| 41 |
conventional mandatory ventilation
(2 times)
|
Traumatology
(1 time)
|
HFOV (1 time)
LDH1 (1 time)
MLCK (1 time)
|
1998 Stress response and mode of ventilation in preterm infants.
|
| 42 |
cucumovirus
(2 times)
|
Botany
(1 time)
|
BlCMV (1 time)
CABMV (1 time)
|
1997 First Report of Cowpea Aphid-Borne Mosaic Potyvirus from Cowpeas Grown Commercially in the U.S.
|
| 43 |
cyclophosphamide, methotrexate, and vincristine
(2 times)
|
Gynecology
(1 time)
|
CAP (1 time)
M-VAC (1 time)
|
1990 [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
|
| 44 |
cytomegalovirus lysate
(2 times)
|
Dermatology
(1 time)
|
Mtb (2 times)
anti-TNF (1 time)
IFN (1 time)
|
2013 Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis.
|
| 45 |
cytomegalovirus promoter/enhancer
(2 times)
|
Biochemistry
(1 time)
|
AdV (1 time)
NLS (1 time)
PCR (1 time)
|
2002 The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
|
| 46 |
promoter-cytomegalovirus
(2 times)
|
Stem Cells
(1 time)
|
BTHS (1 time)
DES (1 time)
EF-1alpha (1 time)
|
2007 Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner.
|
| 47 |
QuantiFERON-cytomegalovirus
(2 times)
|
Allergy and Immunology
(1 time)
|
allo-SCT (1 time)
CI (1 time)
ICS (1 time)
|
2012 Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.
|
| 48 |
Ad-CMV-rNIS, using the cytomegalovirus
(1 time)
|
Neoplasms
(1 time)
|
NIS (1 time)
rNIS (1 time)
|
2004 Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats.
|
| 49 |
anti-CMV antibody for mother-to-fetus cytomegalovirus
(1 time)
|
Medicine
(1 time)
|
---
|
2014 Prophylactic intravenous immunoglobulin injections to mothers with primary cytomegalovirus infection.
|
| 50 |
C virus, cytomegalovirus
(1 time)
|
Sequence Analysis
(1 time)
|
CV (1 time)
HAV (1 time)
|
2018 Development of a Bead-Based Multiplex Assay for the Analysis of the Serological Response against the Six Pathogens HAV, HBV, HCV, CMV, T. gondii, and H. pylori.
|
| 51 |
Canada milk vetch
(1 time)
|
Botany
(1 time)
|
2-PCPGCA (1 time)
|
2010 Biocontrol treatments confer protection against Verticillium dahliae infection of potato by inducing antimicrobial metabolites.
|
| 52 |
canalicular membrane microvilli
(1 time)
|
Gastroenterology
(1 time)
|
BADP (1 time)
PCD (1 time)
|
1997 Large intravenous loads of bilirubin photoconversion products, in contrast to bilirubin, do not cause cholestasis in bile acid-depleted pigs.
|
| 53 |
cancer vaccine using a cytomegalovirus
(1 time)
|
Neoplasms
(1 time)
|
---
|
2016 Reviving virus based cancer vaccines by using cytomegalovirus vectors expressing modified tumor antigens.
|
| 54 |
candidate vaccines against cytomegalovirus
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2020 The Status of Vaccine Development Against the Human Cytomegalovirus.
|
| 55 |
cardiac and major vascular
(1 time)
|
Anesthesiology
(1 time)
|
DAS (1 time)
ICU (1 time)
PAC (1 time)
|
2009 The need for specialized preanesthesia clinics for day admission cardiac and major vascular surgery patients.
|
| 56 |
cardiometabolic variables
(1 time)
|
Metabolism
(1 time)
|
AA (1 time)
PAI-1 (1 time)
tPA (1 time)
|
2008 The relationship between cardiometabolic and hemostatic variables: influence of race.
|
| 57 |
Cardiomyocyte microvesicles
(1 time)
|
Vascular Diseases
(1 time)
|
CRP (1 time)
miRNA (1 time)
MV (1 time)
|
2020 Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?
|
| 58 |
cardiotropic viruses, including adenovirus, cytomegalovirus
(1 time)
|
Cardiology
(1 time)
|
ARVD/C (1 time)
|
2002 The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
| 59 |
Cassava mosaic disease
(1 time)
|
Virology
(1 time)
|
ACMV (1 time)
CR (1 time)
EACMV (1 time)
|
2012 Complete genome sequencing of two causative viruses of cassava mosaic disease in Ghana.
|
| 60 |
Cassava mosaic virus
(1 time)
|
Medicine
(1 time)
|
ACMV (1 time)
CMD (1 time)
|
2019 Response of cassava cultivars to African cassava mosaic virus infection across a range of inoculum doses and plant ages.
|
| 61 |
cauliflower mosaic virus
(1 time)
|
Biomedical Engineering
(1 time)
|
SEM (1 time)
sGFP (1 time)
|
2005 A novel microsurgery method for intact plant tissue at the single cell level using ArF excimer laser microprojection.
|
| 62 |
cell membrane vehicle
(1 time)
|
Nanotechnology
(1 time)
|
Ce6 (1 time)
ICD (1 time)
SFN (1 time)
|
2021 Photodynamic Therapy in Combination with Sorafenib for Enhanced Immunotherapy of Lung Cancer.
|
| 63 |
cell transplantation, including anticytomegalovirus
(1 time)
|
Hematology
(1 time)
|
---
|
2014 Diagnosis and treatment of cytomegalovirus 2013.
|
| 64 |
cell-mediated cytolytic activity during cytomegalovirus
(1 time)
|
Virology
(1 time)
|
GPCMV (1 time)
LGL (1 time)
PBMC (1 time)
|
1988 Peripheral blood mononuclear cell-mediated cytolytic activity during cytomegalovirus (CMV) infection of guinea pigs.
|
| 65 |
Cell-mediated cytotoxicity against cytomegalovirus
(1 time)
|
Virology
(1 time)
|
PBMC (1 time)
|
1996 Non-radioactive assay of natural killer cell-mediated cytotoxicity against cytomegalovirus-infected fibroblasts by DNA fragmentation ELISA.
|
| 66 |
cell-mediated restriction of cytomegalovirus
(1 time)
|
Allergy and Immunology
(1 time)
|
CPE (1 time)
|
2006 [T cell-mediated protective effect in cytomegalovirus infected murine astrocytes].
|
| 67 |
cellular volume
(1 time)
|
Pulmonary Medicine
(1 time)
|
---
|
1998 [Oxygen transport capacity of blood in athletes with malarial infection].
|
| 68 |
cement mass volume
(1 time)
|
Orthopedics
(1 time)
|
CT (1 time)
|
2020 Effect of unilateral pulsed jet lavage prior to vertebroplasty on the intravertebral pressure and cement distribution.
|
| 69 |
ceramic microbial vessel
(1 time)
|
Biotechnology
(1 time)
|
MBR (1 time)
QQ (1 time)
|
2013 Design of quorum quenching microbial vessel to enhance cell viability for biofouling control in membrane bioreactor.
|
| 70 |
cerebellomesencephalic vein
(1 time)
|
Neurosurgery
(1 time)
|
SCIT (1 time)
|
2019 The Purely Endoscopic Supracerebellar Infratentorial Approach for Resecting Pineal Region Tumors with Preservation of Cerebellomesencephalic Vein: Technical Note and Preliminary Clinical Outcomes.
|
| 71 |
certain viral infections including cytomegalovirus
(1 time)
|
Neurology
(1 time)
|
NCC (1 time)
|
2011 [Infectious ventriculitis in relation with neurocysticercosis in Burkina Faso].
|
| 72 |
certain viruses, including cytomegalovirus
(1 time)
|
Allergy and Immunology
(1 time)
|
KIRs (1 time)
MHC (1 time)
NK (1 time)
|
1998 Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog.
|
| 73 |
Cervical mucus viscosity
(1 time)
|
Gynecology
(1 time)
|
BBT (1 time)
FT (1 time)
LAP (1 time)
|
1978 The value of simple tests in the detection of human ovulation.
|
| 74 |
chemotherapy regimens, such as methotrexate-vinblastine-cisplatin
(1 time)
|
Urology
(1 time)
|
GC (1 time)
M-VAC (1 time)
|
2005 Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
|
| 75 |
child-to-mother transmission of cytomegalovirus
(1 time)
|
Pediatrics
(1 time)
|
---
|
2004 Prevention of child-to-mother transmission of cytomegalovirus among pregnant women.
|
| 76 |
childhood vaccines, cytomegalovirus
(1 time)
|
Gastroenterology
(1 time)
|
CI (1 time)
EBV (1 time)
IBD (1 time)
|
2018 Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
|
| 77 |
Chinese man with cytomegalovirus
(1 time)
|
Medicine
(1 time)
|
---
|
1993 Rectal perforation after barium enema in a patient with cytomegalovirus colitis--a case report.
|
| 78 |
chromatophore membrane vesicle
(1 time)
|
Biotechnology
(1 time)
|
bCMV (1 time)
bcp (1 time)
|
2017 Characterization of ATPase Activity of Free and Immobilized Chromatophore Membrane Vesicles of Rhodobacter sphaeroides.
|
| 79 |
chronic graft-vs-host disease, cytomegalovirus
(1 time)
|
Allergy and Immunology
(1 time)
|
post-HSCT (1 time)
|
2016 Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant.
|
| 80 |
chronic mouse vitritis
(1 time)
|
Cell Biology
(1 time)
|
CIV (1 time)
PMN (1 time)
|
1987 Chronic idiopathic vitritis. Cytopathogenicity of unusual bacteria for vitreous polymorphonuclear leukocytes.
|
| 81 |
chronic viruses such as cytomegalovirus
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2010 Metabolic syndrome, hormones, and maintenance of T cells during aging.
|
| 82 |
ciliary muscle volume
(1 time)
|
Optometry
(1 time)
|
---
|
2014 Guinea pig ciliary muscle development.
|
| 83 |
circulating anticytomegalovirus
(1 time)
|
Medicine
(1 time)
|
---
|
1990 [Cytomegalovirus and herpes simplex virus antibodies in patients with idiopathic ulcerative rectocolitis].
|
| 84 |
Circulating VSTs to cytomegalovirus
(1 time)
|
Cell Biology
(1 time)
|
AdV (1 time)
AR (1 time)
EBV (1 time)
|
2020 The effects of β1 and β1+2 adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion of virus-specific T cells: implications for cellular therapy and the anti-viral immune effects of exercise.
|
| 85 |
cisplatin plus mitomycin plus vindesine
(1 time)
|
Neoplasms
(1 time)
|
BM (1 time)
CFU-GM (1 time)
PB (1 time)
|
1992 Effect of chemotherapy on colony-forming unit-granulocyte macrophage from bone marrow and peripheral blood in patients with lung cancer.
|
| 86 |
cisplatin, mitomycin C and vindesine
(1 time)
|
Pulmonary Medicine
(1 time)
|
NSCLC (1 time)
|
1993 [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
|
| 87 |
climate model variation
(1 time)
|
Natural Science Disciplines
(1 time)
|
---
|
2018 Contrasting streamflow regimes induced by melting glaciers across the Tien Shan - Pamir - North Karakoram.
|
| 88 |
clinical manifestations of congenital cytomegalovirus
(1 time)
|
Perinatology
(1 time)
|
---
|
2004 Differential clinical manifestations of congenital cytomegalovirus infection between dizygotic twins: a case report.
|
| 89 |
clinical vaccine strategy for cytomegalovirus
(1 time)
|
Hematology
(1 time)
|
CTL (1 time)
HCT (1 time)
HLA (1 time)
|
2002 Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice.
|
| 90 |
Clinically manifest cytomegalovirus
(1 time)
|
Medicine
(1 time)
|
---
|
1988 [Hyperimmunoglobulin treatment in CMV infections following heart transplantation].
|
| 91 |
cloned into expression plasmid pCI under either a viral
(1 time)
|
Allergy and Immunology
(1 time)
|
CTL (1 time)
|
2000 Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control.
|
| 92 |
cloud motion vector
(1 time)
|
Biosensing Techniques
(1 time)
|
DNI (1 time)
FY-4A (1 time)
GHI (1 time)
|
2020 Very Short-Term Surface Solar Irradiance Forecasting Based On FengYun-4 Geostationary Satellite.
|
| 93 |
CMV and EBV infections by DNA-in situ hybridization
(1 time)
|
Pathology
(1 time)
|
EBV (1 time)
PsA (1 time)
RA (1 time)
|
2004 Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization.
|
| 94 |
CMV and HSV in ALL children compared to controls
(1 time)
|
Hematology
(1 time)
|
ALL (1 time)
EBV (1 time)
hBD-1 (1 time)
|
2009 Association between DEFB1 gene haplotype and herpes viruses seroprevalence in children with acute lymphoblastic leukemia.
|
| 95 |
CMV disease
(1 time)
|
Nephrology
(1 time)
|
---
|
1993 Cytomegalovirus colitis in chronic renal failure.
|
| 96 |
CMV DNAemia
(1 time)
|
Natural Science Disciplines
(1 time)
|
BKPyV (1 time)
DNAemia (1 time)
|
2020 Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation.
|
| 97 |
CMV vector only
(1 time)
|
Endocrinology
(1 time)
|
IGF-II (1 time)
|
1996 Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
|
| 98 |
CMV without PEEP
(1 time)
|
Anesthesiology
(1 time)
|
ARDS (1 time)
CMV-PEEP (1 time)
IRV (1 time)
|
1998 Effect of inverse I:E ratio ventilation on pulmonary gas exchange in acute respiratory distress syndrome.
|
| 99 |
CMV-Ig
(1 time)
|
Medicine
(1 time)
|
---
|
2004 Successful treatment of Good syndrome with cytomegalovirus duodenoenteritis using a combination of ganciclovir and immunoglobulin with high anti-cytomegalovirus antibody titer.
|
| 100 |
CMV-miR-29b vector, which uses cytomegalovirus
(1 time)
|
Medicine
(1 time)
|
Col1a1 (1 time)
ECM (1 time)
KEGG (1 time)
|
2020 A strategic expression method of miR-29b and its anti-fibrotic effect based on RNA-sequencing analysis.
|
A Search Service for Abbreviation / Long Form